Claudio Sorino1, Claudio Pedone2, Nicola Scichilone3. 1. Biomedical Department of Internal and Specialist Medicine, Section of Pulmonology, University of Palermo, Italy; Division of Pulmonology, ASST Lariana S. Anna Hospital of Como, Italy. Electronic address: claudiosorino@libero.it. 2. Unit of Geriatrics, University Campus Bio-Medico, Rome, Italy. Electronic address: c.pedone@unicampus.it. 3. Biomedical Department of Internal and Specialist Medicine, Section of Pulmonology, University of Palermo, Italy. Electronic address: nicola.scichilone@unipa.it.
Abstract
BACKGROUND: The coexistence of asthma and chronic obstructive pulmonary disease (asthma-COPD overlap syndrome: ACOS) is increasingly recognized but data about its prevalence and long-term mortality are needed. METHODS: Prevalence of ACOS and 15-year mortality rates were assessed in 1065 subjects aged >65years, enrolled in the SA.R.A. study, with complete clinical, lung functional and follow-up data. Physical performance, disease-related disability, and health-related quality of life (HRQL) were also evaluated. RESULTS: ACOS was found in 11.1% of subjects (29.4% of those previously diagnosed with COPD and 19.7% of those with asthma). ACOS was positively associated with impaired physical performance, functional ability, and HRQL. Individuals with ACOS had higher mortality rates than controls (7.17 per 100 person-years; mortality rate ratio: 1.83). After adjustment for the main confounders, the risk of all-cause mortality remained significantly increased in subjects with ACOS (HR: 1.82), COPD (HR: 2.12), and restriction (HR: 2.41), but not asthma. CONCLUSIONS: Long-term prognosis of ACOS was similar to COPD, and worse than asthma and healthy controls. ACOS had a significant impact on physical performance, functional ability, and HRQL.
BACKGROUND: The coexistence of asthma and chronic obstructive pulmonary disease (asthma-COPD overlap syndrome: ACOS) is increasingly recognized but data about its prevalence and long-term mortality are needed. METHODS: Prevalence of ACOS and 15-year mortality rates were assessed in 1065 subjects aged >65years, enrolled in the SA.R.A. study, with complete clinical, lung functional and follow-up data. Physical performance, disease-related disability, and health-related quality of life (HRQL) were also evaluated. RESULTS: ACOS was found in 11.1% of subjects (29.4% of those previously diagnosed with COPD and 19.7% of those with asthma). ACOS was positively associated with impaired physical performance, functional ability, and HRQL. Individuals with ACOS had higher mortality rates than controls (7.17 per 100 person-years; mortality rate ratio: 1.83). After adjustment for the main confounders, the risk of all-cause mortality remained significantly increased in subjects with ACOS (HR: 1.82), COPD (HR: 2.12), and restriction (HR: 2.41), but not asthma. CONCLUSIONS: Long-term prognosis of ACOS was similar to COPD, and worse than asthma and healthy controls. ACOS had a significant impact on physical performance, functional ability, and HRQL.
Authors: Franziska C Trudzinski; Rudolf A Jörres; Peter Alter; Julia Walter; Henrik Watz; Andrea Koch; Matthias John; Marek Lommatzsch; Claus F Vogelmeier; Hans-Ulrich Kauczor; Tobias Welte; Jürgen Behr; Amanda Tufman; Robert Bals; Felix J F Herth; Kathrin Kahnert Journal: Sci Rep Date: 2022-05-24 Impact factor: 4.996
Authors: Tetyana Kendzerska; Mohsen Sadatsafavi; Shawn D Aaron; Teresa M To; M Diane Lougheed; J Mark FitzGerald; Andrea S Gershon Journal: PLoS One Date: 2017-03-16 Impact factor: 3.240
Authors: Carlos A Vaz Fragoso; Terrence E Murphy; George O Agogo; Heather G Allore; Gail J McAvay Journal: Int J Chron Obstruct Pulmon Dis Date: 2017-02-03
Authors: Camilla Boslev Baarnes; Peter Kjeldgaard; Mia Nielsen; Marc Miravitlles; Charlotte Suppli Ulrik Journal: NPJ Prim Care Respir Med Date: 2017-01-05 Impact factor: 2.871